Nurix Therapeutics to Participate in Upcoming Investor Conferences
SAN FRANCISCO, April 03, 2024 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein […]
Mobilicom Launches New Cybersecure Mesh Networking Solution for Long-Range Uncrewed Platforms
New MCU-300 delivers cybersecure mesh networking long-range, high-speed, high-definition video and data Latest product further expands Mobilicom into the […]
Singing Machine Secures $2 Million Senior Credit Facility
Company Expands Non-Dilutive Working Capital Funding to Support Growth Fort Lauderdale, FL, April 03, 2024 (GLOBE NEWSWIRE) — The Singing […]
Eyenovia to Feature its Suite of Commercial Products and the Optejet Dispenser at Upcoming National Eyecare Meetings
Company to demonstrate Mydcombi™ and Avenova® and Share Data for Clobetasol Propionate Ophthalmic Suspension 0.05% at the American Society of […]
Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting
BOTHELL, Wash., April 03, 2024 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on […]
Reliance, Inc. Completes Acquisition of American Alloy Steel, Inc.
SCOTTSDALE, Ariz., April 03, 2024 (GLOBE NEWSWIRE) — Reliance, Inc. (NYSE: RS) announced that effective April 1, 2024, it has […]
TC Energy appoints Sean O’Donnell as Executive Vice-President and Chief Financial Officer
CALGARY, Alberta, April 03, 2024 (GLOBE NEWSWIRE) — – News Release – TC Energy Corporation (TSX, NYSE: TRP) (TC Energy […]
Brown & Brown, Inc. acquires the assets of CHAPP, Inc. and Citrus Insurance Services, Inc.
DAYTONA BEACH, Fla., April 03, 2024 (GLOBE NEWSWIRE) — J. Scott Penny, chief acquisitions officer of Brown & Brown, Inc. […]
TSX News -
Alamos Gold Provides Notice of First Quarter 2024 Results and Conference Call, and Annual General and Special Meeting of Shareholders
TORONTO, April 03, 2024 (GLOBE NEWSWIRE) — Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) plans to release its […]
BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Recent acquisition of Adaptive Phage Therapeutics creates leader in phage therapy with advanced, clinical-stage pipeline Closed concurrent $50 million […]
